Taiwan, Japan Eye Drug Regulation Streamlining To Curb Costs
This article was originally published in PharmAsia News
Executive Summary
Regulators from Japan and Taiwan met in late December to review prospects for convergence and pointed to manufacturing and new drug approvals as areas that were ripe for harmonization agreements.